FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3041436986> ?p ?o ?g. }

• W3041436986 endingPage "601" @default.
• W3041436986 startingPage "601" @default.
• W3041436986 abstract "Background: Chronic pulmonary diseases are characterized by airway remodeling due to complex multicellular responses and the production of free oxygen radicals. They lead to a progressive decline of pulmonary functions. Adelmidrol is an analogue of palmitoylethanolamide (PEA), which is a well-known anti-inflammatory and anti-oxidant compound. In this study, we investigated the efficacy of adelmidrol (10 mg/Kg) for bleomycin-induced pulmonary fibrosis in mice. Methods: Bleomycin intratracheal administration was performed on the first day and for the following twenty-one days, mice were treated with adelmidrol (10 mg/Kg). Results: The survival rate and body weight gain were recorded daily. At the end of the experiment, adelmidrol-administered animals showed reduced airway infiltration by inflammatory cells, Myeloperoxidase (MPO) activity, and pro-inflammatory cytokine overexpression (IL,6 IL-1β, TNF-α, and TGF-1β). Moreover, adelmidrol treatment was able to manage the significant incapacity of antioxidants and elevation of the oxidant burden, as shown by the MDA, SOD, and GSH levels and decreased nitric oxide production. It was also able to significantly modulate the JAK2/STAT3 and IκBα/NF-kB pathway. Histologic examination of the lung tissues showed reduced sample injury, mast cell degranulation, chymase activity, and collagen deposition. Conclusions: In sum, our results propose adelmidrol as a therapeutic approach in the treatment of pulmonary fibrosis." @default.
• W3041436986 created "2020-07-16" @default.
• W3041436986 creator A5005277928 @default.
• W3041436986 creator A5012495688 @default.
• W3041436986 creator A5019372340 @default.
• W3041436986 creator A5022376648 @default.
• W3041436986 creator A5027732860 @default.
• W3041436986 creator A5049935256 @default.
• W3041436986 creator A5052387572 @default.
• W3041436986 creator A5053839749 @default.
• W3041436986 creator A5076323717 @default.
• W3041436986 creator A5084349553 @default.
• W3041436986 creator A5086038807 @default.
• W3041436986 date "2020-07-09" @default.
• W3041436986 modified "2023-10-02" @default.
• W3041436986 title "Adelmidrol: A New Promising Antioxidant and Anti-Inflammatory Therapeutic Tool in Pulmonary Fibrosis" @default.
• W3041436986 cites W1414541266 @default.
• W3041436986 cites W1524256661 @default.
• W3041436986 cites W1590514634 @default.
• W3041436986 cites W1687290736 @default.
• W3041436986 cites W1915196633 @default.
• W3041436986 cites W1918392102 @default.
• W3041436986 cites W1968477506 @default.
• W3041436986 cites W1982179568 @default.
• W3041436986 cites W1983310681 @default.
• W3041436986 cites W1986602687 @default.
• W3041436986 cites W1993026721 @default.
• W3041436986 cites W1993559550 @default.
• W3041436986 cites W2002856497 @default.
• W3041436986 cites W2002901364 @default.
• W3041436986 cites W2006944304 @default.
• W3041436986 cites W2008409819 @default.
• W3041436986 cites W2012357237 @default.
• W3041436986 cites W2018439316 @default.
• W3041436986 cites W2018624955 @default.
• W3041436986 cites W2018809578 @default.
• W3041436986 cites W2020065240 @default.
• W3041436986 cites W2024372446 @default.
• W3041436986 cites W2034386687 @default.
• W3041436986 cites W2043695204 @default.
• W3041436986 cites W2048593238 @default.
• W3041436986 cites W2057536129 @default.
• W3041436986 cites W2059829735 @default.
• W3041436986 cites W2060928333 @default.
• W3041436986 cites W2062828989 @default.
• W3041436986 cites W2065059030 @default.
• W3041436986 cites W2065977597 @default.
• W3041436986 cites W2076195364 @default.
• W3041436986 cites W2077356917 @default.
• W3041436986 cites W2081406906 @default.
• W3041436986 cites W2088272869 @default.
• W3041436986 cites W2088808945 @default.
• W3041436986 cites W2100334041 @default.
• W3041436986 cites W2102206799 @default.
• W3041436986 cites W2104974169 @default.
• W3041436986 cites W2106408170 @default.
• W3041436986 cites W2111276435 @default.
• W3041436986 cites W2111791469 @default.
• W3041436986 cites W2114054457 @default.
• W3041436986 cites W2125262516 @default.
• W3041436986 cites W2125410210 @default.
• W3041436986 cites W2131348376 @default.
• W3041436986 cites W2135265438 @default.
• W3041436986 cites W2137569729 @default.
• W3041436986 cites W2143166659 @default.
• W3041436986 cites W2147507778 @default.
• W3041436986 cites W2162105352 @default.
• W3041436986 cites W2166728827 @default.
• W3041436986 cites W2167351713 @default.
• W3041436986 cites W2175291270 @default.
• W3041436986 cites W2329571226 @default.
• W3041436986 cites W2329613939 @default.
• W3041436986 cites W2412271549 @default.
• W3041436986 cites W2414595141 @default.
• W3041436986 cites W2436366831 @default.
• W3041436986 cites W2471345196 @default.
• W3041436986 cites W2519408518 @default.
• W3041436986 cites W2560824455 @default.
• W3041436986 cites W2561285627 @default.
• W3041436986 cites W2598265559 @default.
• W3041436986 cites W2624064951 @default.
• W3041436986 cites W2727215970 @default.
• W3041436986 cites W2799472619 @default.
• W3041436986 cites W2804299827 @default.
• W3041436986 cites W2916127417 @default.
• W3041436986 cites W2947388960 @default.
• W3041436986 cites W2963956499 @default.
• W3041436986 doi "https://doi.org/10.3390/antiox9070601" @default.
• W3041436986 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7402091" @default.
• W3041436986 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32660140" @default.
• W3041436986 hasPublicationYear "2020" @default.
• W3041436986 type Work @default.
• W3041436986 sameAs 3041436986 @default.
• W3041436986 citedByCount "43" @default.
• W3041436986 countsByYear W30414369862020 @default.
• W3041436986 countsByYear W30414369862021 @default.
• W3041436986 countsByYear W30414369862022 @default.
• W3041436986 countsByYear W30414369862023 @default.

• next